{"id":8107,"date":"2026-02-10T14:52:11","date_gmt":"2026-02-10T14:52:11","guid":{"rendered":"https:\/\/www.europesays.com\/dk\/8107\/"},"modified":"2026-02-10T14:52:11","modified_gmt":"2026-02-10T14:52:11","slug":"hims-hers-says-novo-nordisk-lawsuit-blatant-attack-on-millions-of-americans","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/dk\/8107\/","title":{"rendered":"Hims &#038; Hers says Novo Nordisk lawsuit \u2018blatant attack\u2019 on millions of Americans"},"content":{"rendered":"\n<p class=\"yf-vbsvxt\">Hims &amp; Hers (<a href=\"https:\/\/www.tipranks.com\/stocks\/hims?utm_source=finance.yahoo.com&amp;utm_medium=referral\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:HIMS;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">HIMS<\/a>) said in a post on X, formerly Twitter: \u201cNovo Nordisk\u2019s (<a href=\"https:\/\/www.tipranks.com\/stocks\/nvo?utm_source=finance.yahoo.com&amp;utm_medium=referral\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:NVO;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">NVO<\/a>) lawsuit is a blatant attack by a Danish company on millions of Americans who rely on compounded medications for access to personalized care. Once again, Big Pharma is weaponizing the US judicial system to limit consumer choice. This lawsuit attacks more than just one medication or company \u2013 it directly assaults a well-established, vital component of US pharmacy practice that has improved patient care for everything from obesity to infertility to cancer. Hims &amp; Hers has a long history of providing safe access to personalized healthcare to millions of Americans, and we will continue to fight to provide choice, affordability, and access.\u201d<\/p>\n<p class=\"yf-vbsvxt\">Published first on <a href=\"https:\/\/thefly.com\/?utm_source=finance.yahoo.com&amp;utm_medium=referral\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:TheFly;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">TheFly<\/a> \u2013 the ultimate source for real-time, market-moving breaking financial news. <a href=\"https:\/\/thefly.com\/?utm_source=finance.yahoo.com&amp;utm_medium=referral\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Try Now&gt;&gt;;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Try Now&gt;&gt;<\/a><\/p>\n<p class=\"yf-vbsvxt\"><a href=\"https:\/\/www.tipranks.com\/screener\/top-smart-score-stocks\/?type=stockAnalysisLanding&amp;utm_source=finance.yahoo.com&amp;utm_medium=referral\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:See today\u2019s best-performing stocks on TipRanks &gt;&gt;;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">See today\u2019s best-performing stocks on TipRanks &gt;&gt;<\/a><\/p>\n<p class=\"yf-vbsvxt\">Read More on NVO:<\/p>\n<p class=\"yf-vbsvxt\"><a href=\"https:\/\/www.tipranks.com\/glossary\/d\/disclaimer-disclosure\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Disclaimer &amp; Disclosure;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Disclaimer &amp; Disclosure<\/a><a href=\"https:\/\/www.tipranks.com\/glossary\/c\/contact-editor\" rel=\"nofollow noopener\" target=\"_blank\" data-ylk=\"slk:Report an Issue;elm:context_link;itc:0;sec:content-canvas\" class=\"link \">Report an Issue<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"Hims &amp; Hers (HIMS) said in a post on X, formerly Twitter: \u201cNovo Nordisk\u2019s (NVO) lawsuit is a&hellip;\n","protected":false},"author":2,"featured_media":8108,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[271],"tags":[6820,6821,6823,621,272,6822,6819,6824],"class_list":["post-8107","post","type-post","status-publish","format-standard","has-post-thumbnail","category-novo-nordisk","tag-big-pharma","tag-blatant-attack","tag-danish-company","tag-hims","tag-novo-nordisk","tag-personalized-care","tag-twitter","tag-us-judicial-system"],"share_on_mastodon":{"url":"","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/8107","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/comments?post=8107"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/posts\/8107\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media\/8108"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/media?parent=8107"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/categories?post=8107"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/dk\/wp-json\/wp\/v2\/tags?post=8107"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}